First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery.

Jason BacharachCathleen McCabeMitchell A JacksonSanjay RaoI Paul SinghSebastian HeersinkNathan M RadcliffeRobert WeinstockDario PaggiarinoKeyur Patel

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

Patients undergoing cataract surgery and treated with intraocular DXM showed favorable inflammatory and visual outcomes, without unanticipated safety problems, consistent with results of previous controlled clinical trials.

Keyphrases

cataract surgery
patients undergoing
clinical trial
oxidative stress
mental health
low dose
high dose
double blind
randomized controlled trial
type diabetes
open label
adipose tissue
study protocol
phase iii
weight loss
glycemic control